BIOLUnknown
BIOLASE, INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for BIOLASE, INC (BIOL), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are BIOL insiders buying or selling?
BIOLASE, INC insiders reported 12 open-market buys ($1.3M) and 6 sells ($8.5M) across 18 Form 4 filings — a net selling position of $7.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of May 26, 2023)
Total Form 4 filings
18
SEC EDGAR
Insider filers
7
Insider buys (12)
$1.3M
Insider sells (6)
$8.5M
Insider sentiment
Net sellingNet insider flow of $7.2M in net selling.
Recent BIOL insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 26, 2023 | Schuler Education Foundation | 10% Owner | Sale | 7.9M | $0.43 | $3.3M |
| Dec 9, 2022 | Jonathan T Lord MD | Director | Sale | 3.5K | $0.75 | $2.7K |
| Dec 16, 2021 | Jonathan T Lord MD | Director | Sale | 11.0K | $0.38 | $4.2K |
| Dec 2, 2021 | John R Beaver | President & CEO | Purchase | 70.0K | $0.45 | $31.5K |
| Aug 23, 2021 | John R Beaver | President & CEO | Purchase | 35.0K | $0.61 | $21.4K |
| May 19, 2021 | John R Beaver | President & CEO | Purchase | 40.0K | $0.75 | $30.0K |
| Jun 10, 2020 | FEINBERG LARRY N | 10% Owner | Sale | 5.2M | $0.55 | $2.9M |
| May 15, 2020 | SCHULER JACK W | 10% Owner | Sale | 1.3M | $0.60 | $784.8K |
| Nov 1, 2019 | FEINBERG LARRY N | 10% Owner | Purchase | 17.4K | $57.50 | $1000.0K |
| Jun 27, 2019 | FEINBERG LARRY N | 10% Owner | Sale | 1.0M | $1.50 | $1.5M |
| Dec 15, 2018 | Garrett Sato | Director | Purchase | 5.0K | $1.07 | $5.3K |
| Dec 15, 2018 | Todd Norbe | President and CEO | Purchase | 15.0K | $1.03 | $15.5K |
| Dec 6, 2018 | John R Beaver | EVP & Chief Financial Officer | Purchase | 1.0K | $1.18 | $1.2K |
| Nov 30, 2018 | Garrett Sato | Director | Purchase | 5.0K | $1.22 | $6.1K |
| Nov 21, 2018 | Jonathan T Lord MD | Director | Purchase | 10.0K | $1.36 | $13.6K |
| Aug 17, 2018 | John R Beaver | EVP & Chief Financial Officer | Purchase | 25.0K | $1.67 | $41.8K |
| Aug 14, 2018 | Jonathan T Lord MD | Director | Purchase | 100.0K | $1.31 | $131.1K |
| Aug 14, 2018 | Garrett Sato | Director | Purchase | 5.0K | $1.37 | $6.8K |
Showing the 18 most recent of 18 Form 4 filings for BIOLASE, INC.
Most active BIOL insiders
- John R Beaver5 filings
- Jonathan T Lord MD4 filings
- FEINBERG LARRY N3 filings
- Garrett Sato3 filings
- SCHULER JACK W1 filing
Ask anything about BIOL insider activity
Use Trabud's AI agent to query BIOLASE, INC's Form 4 history in plain English — "Show me BIOL CEO purchases this year" or compare it against any other ticker.
Open the AI agentBIOL insider trading FAQ
Are BIOLASE, INC insiders buying or selling?
Across 18 SEC Form 4 filings, BIOLASE, INC (BIOL) insiders reported 12 open-market purchases totaling $1.3M and 6 sales totaling $8.5M. That is a net selling position of $7.2M.
How many insiders trade BIOL stock?
7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for BIOLASE, INC. The most recent filing was accepted on May 26, 2023.
Where does Trabud get BIOL insider trading data?
All BIOL insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.